# Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia

> **NCT00278265** · PHASE2 · TERMINATED · sponsor: **German CLL Study Group** · enrollment: 12 (actual)

## Conditions studied

- T-Cell Large Granular Lymphocytic Leukemia

## Interventions

- **DRUG:** MTX followed by fludarabine

## Key facts

- **NCT ID:** NCT00278265
- **Lead sponsor:** German CLL Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** slow recruitment
- **Last updated:** 2016-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00278265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00278265, "Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00278265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*